Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S Common Stock
(NY:
NVO
)
46.20
-0.88 (-1.86%)
Streaming Delayed Price
Updated: 11:58 AM EDT, May 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,008,949
Open
46.79
Bid (Size)
46.20 (1,500)
Ask (Size)
46.21 (400)
Prev. Close
47.08
Today's Range
45.54 - 46.84
52wk Range
35.12 - 81.44
Shares Outstanding
N/A
Dividend Yield
5.52%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?
↗
Today 5:25 EDT
Eli Lilly is dominating one of the biggest growth markets in healthcare: the weight loss drug market.
Via
The Motley Fool
Is Novo Nordisk's Rebound for Real--or Just a Head Fake?
↗
May 13, 2026
The worst might be in the rearview mirror.
Via
The Motley Fool
Performance
YTD
-11.8%
-11.8%
1 Month
+21.7%
+21.7%
3 Month
-5.2%
-5.2%
6 Month
-8.1%
-8.1%
1 Year
-29.4%
-29.4%
More News
Read More
Novo Nordisk A/S Q1 Earnings Call Highlights
↗
May 13, 2026
Via
MarketBeat
Topics
Earnings
Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?
↗
May 12, 2026
Via
MarketBeat
Topics
Intellectual Property
Lawsuit
Why Hims & Hers Health Stock Just Crashed
↗
May 12, 2026
Via
The Motley Fool
Topics
Earnings
Lawsuit
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
Via
FinancialNewsMedia
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
From
MarketNewsUpdates.com
Via
GlobeNewswire
BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly
May 11, 2026
Via
Investor Brand Network
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026
Via
Investor Brand Network
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
↗
May 09, 2026
Via
The Motley Fool
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026
From
BioMedWire
Via
GlobeNewswire
Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus
↗
May 08, 2026
Via
MarketBeat
Forget Eli Lilly: These 2 Stocks Have More Upside
↗
May 07, 2026
Via
The Motley Fool
What the FDA's Latest Proposal Means for Lilly, Novo, and Hims
↗
May 07, 2026
Via
MarketBeat
My Top Obesity Stock to Buy and Hold
↗
May 07, 2026
Via
The Motley Fool
Record Highs, Punished Results, and One Very Consequential Apple Rumor
↗
May 06, 2026
Via
Chartmill
3 Absurdly Cheap Growth Stocks to Buy in May 2026
↗
May 04, 2026
Via
The Motley Fool
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months
↗
May 04, 2026
Via
The Motley Fool
Eli Lilly Just Announced Fantastic News for Shareholders
↗
May 04, 2026
Via
The Motley Fool
Topics
Earnings
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)
↗
May 02, 2026
Via
The Motley Fool
Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent
↗
May 01, 2026
Via
MarketBeat
Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge
↗
May 01, 2026
Via
MarketBeat
What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
↗
April 30, 2026
Via
The Motley Fool
Is Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks So
↗
April 28, 2026
Via
The Motley Fool
Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance Means
↗
April 28, 2026
Via
MarketBeat
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 46.20
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 05/14/26 11:58 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.